In an A549-GFP xenograft tumor model, endostatin treatment suppressed tumor growth by increasing the number of apoptotic tumor cells and by inhibiting tumor angiogenesis, defined as a decreased number of CD31+ cells, compared with WT mice [219]. This evidence concerns the gene PECAM1 and neoplasm.